These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36160238)

  • 21. Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.
    Ahn SH; Chan HL; Chen PJ; Cheng J; Goenka MK; Hou J; Lim SG; Omata M; Piratvisuth T; Xie Q; Yim HJ; Yuen MF;
    Hepatol Int; 2010 Feb; 4(1):386-95. PubMed ID: 20305758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward a Better Definition of Acute-on-Chronic Liver Failure.
    Duseja A; Singh SP
    J Clin Exp Hepatol; 2017 Sep; 7(3):262-265. PubMed ID: 28970714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma.
    Bota S; Piscaglia F; Marinelli S; Pecorelli A; Terzi E; Bolondi L
    Liver Cancer; 2012 Nov; 1(3-4):190-200. PubMed ID: 24159584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatitis B: who should be treated?].
    Bradarić N; Kuzmicić N; Bradarić I
    Acta Med Croatica; 2013 Oct; 67(4):311-8. PubMed ID: 24984330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid-enhanced MRI in at-risk patients.
    Park SH; Shim YS; Kim B; Kim SY; Kim YS; Huh J; Park JH; Kim KW; Lee SS
    Eur Radiol; 2021 Jul; 31(7):4751-4763. PubMed ID: 33389037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NIH consensus development statement on management of hepatitis B.
    Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
    NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of chronic hepatitis B with nucleos(t)ide analogues.
    Ohishi W; Chayama K
    Hepatol Res; 2012 Mar; 42(3):219-25. PubMed ID: 22176139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter pilot survey to clarify the clinical features of patients with acute-on-chronic liver failure in Japan.
    Nakayama N; Uemura H; Uchida Y; Tomiya T; Ido A; Inoue K; Genda T; Takikawa Y; Sakaida I; Terai S; Yokosuka O; Shimizu M; Takikawa H; Mochida S
    Hepatol Res; 2018 Mar; 48(4):303-312. PubMed ID: 29341357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute-on-Chronic Liver Failure: Etiology of Chronic and Acute Precipitating Factors and Their Effect on Mortality.
    Gawande A; Gupta GK; Gupta A; Wanjari SJ; Goel V; Rathore V; Bhardwaj H; Nijhawan S
    J Clin Exp Hepatol; 2019; 9(6):699-703. PubMed ID: 31889750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute-on-Chronic Liver Failure (ACLF) in Coastal Eastern India: "A Single-Center Experience".
    Pati GK; Singh A; Misra B; Misra D; Das HS; Panda C; Singh SP
    J Clin Exp Hepatol; 2016 Mar; 6(1):26-32. PubMed ID: 27194893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiles of HBV DNA in a large population of Chinese patients with chronic hepatitis B: implications for antiviral therapy.
    Fung J; Seto WK; Lai CL; Yuen J; Wong DK; Yuen MF
    J Hepatol; 2011 Feb; 54(2):195-200. PubMed ID: 21056499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D.
    Palom A; Rando-Segura A; Vico J; Pacín B; Vargas E; Barreira-Díaz A; Rodríguez-Frías F; Riveiro-Barciela M; Esteban R; Buti M
    JHEP Rep; 2022 Oct; 4(10):100547. PubMed ID: 36052219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic hepatitis B virus infection in Asian countries.
    Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
    J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
    Abruzzi A; Fried B; Alikhan SB
    Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients.
    Jeng WJ; Sheen IS; Chen YC; Hsu CW; Chien RN; Chu CM; Liaw YF
    Hepatology; 2013 Dec; 58(6):1888-96. PubMed ID: 23744454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.
    Shiha G; Ibrahim A; Helmy A; Sarin SK; Omata M; Kumar A; Bernstien D; Maruyama H; Saraswat V; Chawla Y; Hamid S; Abbas Z; Bedossa P; Sakhuja P; Elmahatab M; Lim SG; Lesmana L; Sollano J; Jia JD; Abbas B; Omar A; Sharma B; Payawal D; Abdallah A; Serwah A; Hamed A; Elsayed A; AbdelMaqsod A; Hassanein T; Ihab A; GHaziuan H; Zein N; Kumar M
    Hepatol Int; 2017 Jan; 11(1):1-30. PubMed ID: 27714681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis B.
    Lee HW; Chon YE; Kim BK; Yip TC; Tse YK; Wong GL; Wong VW; Chan HL; Ahn SH
    Eur J Intern Med; 2021 Feb; 84():68-73. PubMed ID: 33288393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indication for treatment and severity of disease in treatment-naive patients with chronic hepatitis B virus infection.
    Post G; Shalev N; Baumgarten A; Shimakawa Y; Lemoine M; Krznaric I; Dupke S; Carganico A; Arastéh K; Ingiliz P
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):723-728. PubMed ID: 30964812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Advances in the Management of Chronic Hepatitis B Including Suppression of Hepatocellular Carcinoma by Entecavir and Interferon.
    Kim SK; Kim SR; Imoto S; Tohyama M; Otono Y; Tamura T; Kim KI; Kobayashi M; Ohtani A; Sugimoto K; Mizuguchi A; Hiramatsu Y; Kudo M
    Oncology; 2015; 89 Suppl 2():60-9. PubMed ID: 26584037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.